Exploring Affordable Curative Therapy for Sickle Cell Disease in Africa: A Comprehensive Overview

Area of Science:

• Hematology
• Public Health
• Genetics

Background:

• Sickle cell disease (SCD) presents significant challenges in Africa, necessitating the development of accessible curative treatments.
• Existing healthcare infrastructure and resources in low- and middle-income countries pose barriers to advanced therapies.

Purpose of the Study:

• To outline the practical considerations for implementing curative SCD treatments in Africa.
• To identify strategies for overcoming economic, ethical, and logistical hurdles in SCD management.

Main Methods:

• The study reviews essential components for developing curative SCD therapies, including infrastructure, workforce training, and national programs.
• It examines cost-effectiveness strategies, ethical guidelines, and the importance of early diagnosis and public awareness.
• The role of accessible disease-modifying therapies as a precursor to curative treatments is emphasized.

Main Results:

• Successful implementation of gene therapy and stem cell transplantation requires substantial healthcare system strengthening.
• Affordability and equitable access are critical, necessitating local manufacturing, government support, and global partnerships.
• Integrating newborn screening and continuous clinical care is vital for identifying eligible patients.

Conclusions:

• A pragmatic approach involves prioritizing accessible disease-modifying therapies while concurrently building capacity for advanced curative treatments.
• International collaboration is essential for knowledge sharing and resource optimization in SCD management.
• Addressing cultural factors and promoting positive attitudes are key to successful SCD care and treatment adoption.